Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

German multicenter study for treatment optimisation in acute lymphoblastic leukemia in adults and adolescents above 15 years (GMALL 07/2003)

Next Previous
X
Search
Trial Profile

German multicenter study for treatment optimisation in acute lymphoblastic leukemia in adults and adolescents above 15 years (GMALL 07/2003)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pegaspargase (Primary) ; Antineoplastics; Asparaginase; Cladribine; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Fludarabine; Granulocyte colony-stimulating factors; Idarubicin; Mercaptopurine; Methotrexate; Prednisolone; Teniposide; Tioguanine; Vincristine; Vindesine
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 17 Aug 2022 Status changed from recruiting to completed.
    • 14 Dec 2021 Results assessing the initial and post-prephase CD20 expression in GMALL08/2013 pts and correlated the values with MRD response after Induction I (Ind I) and Consolidation I (Cons I) , A historical B-ALL GMALL07/2003 cohort without R treatment and with available CD20 expression and MRD data was used to evaluate for R unrelated effects presented at the 63rd American Society of Hematology Annual Meeting and Exposition
    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003813).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top